loadpatents
name:-0.027709007263184
name:-0.034746885299683
name:-0.00055909156799316
Sedlacek; Hans-Harald Patent Filings

Sedlacek; Hans-Harald

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sedlacek; Hans-Harald.The latest application filed is for "pharmaceutical composition for the prophylaxis and/or treatment of viral diseases".

Company Profile
0.27.20
  • Sedlacek; Hans-Harald - Marburg DE
  • Sedlacek; Hans Harald - D-35001 Marburg DE
  • Sedlacek; Hans-Harald - Marburg an der Lahn DE
  • Sedlacek; Hans-Harald - Marburgh an der Lahn DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for the prophylaxis or treatment of viral diseases
Grant 8,313,751 - Planz , et al. November 20, 2
2012-11-20
Single-chain multiple antigen-binding molecule, its preparation and use
Grant 7,838,637 - Kontermann , et al. November 23, 2
2010-11-23
Pharmaceutical Composition For The Prophylaxis And/or Treatment Of Viral Diseases
App 20100239563 - Ludwig; Stephan ;   et al.
2010-09-23
Chimeric antibody against tumor associated antigens and its use in diagnosing tumors
Grant 7,662,383 - Bosslet , et al. February 16, 2
2010-02-16
Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use
App 20090326206 - Kontermann; Roland ;   et al.
2009-12-31
Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
App 20090246132 - Bosslet; Klaus ;   et al.
2009-10-01
Compositions And Methods For The Prophylaxis Or Treatment Of Viral Diseases
App 20090191207 - Planz; Oliver ;   et al.
2009-07-30
Caspase Inhibitors, Especially Caspase 3 Inhibitors, For The Treatment Of Influenza
App 20090155270 - Ludwig; Stefan ;   et al.
2009-06-18
Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza
App 20070172489 - Ludwig; Stefan ;   et al.
2007-07-26
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
Grant 7,241,595 - Kolar , et al. July 10, 2
2007-07-10
Use of active ingredients for the prophylaxis and/or therapy of viral diseases
App 20060247161 - Planz; Oliver ;   et al.
2006-11-02
Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
App 20060159682 - Bosslet; Klaus ;   et al.
2006-07-20
Enveloped miroorganism
App 20050244374 - Goebel, Werner ;   et al.
2005-11-03
Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
Grant 6,926,896 - Bosslet , et al. August 9, 2
2005-08-09
Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
App 20050129694 - Ludwig, Stephan ;   et al.
2005-06-16
Single-chain multiple antigen-binding molecule, its preparation and use
App 20050004352 - Kontermann, Roland ;   et al.
2005-01-06
Single-chain multiple antigen-binding molecule, its preparation and use
Grant 6,759,518 - Kontermann , et al. July 6, 2
2004-07-06
Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
App 20040110682 - Heidtmann, Hans Heinrich ;   et al.
2004-06-10
Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof
App 20040091488 - Seeman, Gerhard ;   et al.
2004-05-13
Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
Grant 6,670,147 - Heidtmann , et al. December 30, 2
2003-12-30
Nucleic acid constructs containing hybrid promoters for use in gene therapy
App 20030187245 - Seifart, Klaus-Heinrich ;   et al.
2003-10-02
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
Grant 6,610,299 - Kolar , et al. August 26, 2
2003-08-26
Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof
Grant 6,548,067 - Seeman , et al. April 15, 2
2003-04-15
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
App 20030064482 - Kolar, Cenek ;   et al.
2003-04-03
Novel complex-forming proteins
App 20030054409 - Jerome, Valerie ;   et al.
2003-03-20
Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle
App 20030018005 - Sedlacek, Hans-Harald ;   et al.
2003-01-23
Self-enhancing, pharmacologically controllable expression systems
App 20030008398 - Mueller, Rolf ;   et al.
2003-01-09
Self-enhancing, pharmacologically controllable expression systems
Grant 6,482,618 - Mueller , et al. November 19, 2
2002-11-19
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
Grant 6,475,486 - Kolar , et al. November 5, 2
2002-11-05
Self-enhancing, pharmacologically controllable expression systems
App 20020151049 - Mueller, Rolf ;   et al.
2002-10-17
Expression Systems Comprising Chimeric Promoters With Binding Sites For Recombinant Transcription Factors
App 20020137699 - MUELLER, ROLF ;   et al.
2002-09-26
Cell-specific active compounds regulated by the cell cycle
Grant 6,384,202 - Sedlacek , et al. May 7, 2
2002-05-07
Self-enhancing, pharmacologically controllable expression systems
Grant 6,383,785 - Mueller , et al. May 7, 2
2002-05-07
Nucleic acid construct for the cell cycle regulated expression of structural genes
Grant 6,380,170 - Muller , et al. April 30, 2
2002-04-30
DNA for expression under control of a cell cycle-dependent promoter
Grant 6,358,732 - Sedlacek , et al. March 19, 2
2002-03-19
Nucleic acid constructs containing genes encoding transport signals
Grant 6,235,526 - Sedlacek , et al. May 22, 2
2001-05-22
Promoter of the cdc25B gene, its preparation and use
Grant 6,033,856 - Koerner , et al. March 7, 2
2000-03-07
Cell-specific gene therapy using as promoter novel promoters for tissue inhibitors of metalloproteinase-3
Grant 5,854,019 - Sedlacek , et al. December 29, 1
1998-12-29
Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
Grant 5,830,880 - Sedlacek , et al. November 3, 1
1998-11-03
Use of pairs of leucine zipper peptides in immunoassay methods
Grant 5,643,731 - Bosslet , et al. July 1, 1
1997-07-01
1,3-thiazoles and their use as immunomodulators
Grant 4,762,848 - Scheunemann , et al. August 9, 1
1988-08-09
Anthracycline derivatives and their use as cytostatics
Grant 4,713,371 - Aretz , et al. December 15, 1
1987-12-15
Use of the diterpene derivative forskolin for immunostimulation
Grant 4,578,399 - Schorlemmer , et al. March 25, 1
1986-03-25
Process for immunologic determination tests
Grant 4,332,783 - Pernice , et al. June 1, 1
1982-06-01
Methods for the detection of antimitochondrial and antinuclear antibodies
Grant 4,296,201 - Ax , et al. October 20, 1
1981-10-20
Immunologic determination method
Grant 4,166,106 - Sedlacek , et al. August 28, 1
1979-08-28
Tanned thrombocytes
Grant 4,157,383 - Sedlacek , et al. June 5, 1
1979-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed